Sarepta stock falls on FDA gene therapy Elevidys comment
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., throughout the Forbes Healthcare Summit in Recent York, US, ...
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., throughout the Forbes Healthcare Summit in Recent York, US, ...